Liver Deaths Prompt FDA Boxed Warning for Elevidys for DMD – Medscape
- Liver Deaths Prompt FDA Boxed Warning for Elevidys for DMD Medscape
- FDA’s stronger warning on Sarepta gene therapy raises new questions about heart risk statnews.com
- US FDA limits Duchenne Gene therapy after teen liver failures | Tap to know more | Inshorts Inshorts
- This Week’s Biopharma News: New Restrictions on Sarepta Gene Therapy The Medicine Maker
- FDA hits Sarepta with liver warning labelling for its DMD drug Elevidys European Pharmaceutical Review